Delivery Order SPE2DB22D1106-SPE2DB25FEKV9
Award Date
4/28/25
Potential Completion Date
5/19/25
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $39,228.60 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of IMBRUVICA 140 MG CAPSULE 90S, a prescription medication. The award does not have a set-aside designation. The contract has an ultimate completion date of August 27, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to...
This federal contract award, valued at $16,233.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of IMBRUVICA 140 MG CAPSULE 90S, a prescription medication. The contract has a firm fixed price and an ultimate completion date of May 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides a comprehensive global...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,116.87 firm fixed-price contract is for the supply of IMBRUVICA 140 MG CAPSULE 90S, a prescription medication. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides global pharmaceutical support to military healthcare programs. The...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of IMBRUVICA 140 MG CAPSULE 90S. The order has a ceiling value of $7,845.72 and is a firm fixed price contract. The award date is August 8, 2024, and the ultimate completion date is August 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,233.74, is for the delivery of IMBRUVICA 140 MG CAPSULES. It is a Firm Fixed Price Delivery Order contract with a completion date of February 27, 2025. The contract is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a firm fixed price of $7,322.67 and a completion date of September 17, 2024. The contract is for the supply of IMBRUVICA 420 MG TABLET 28S, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of IMBRUVICA 140 MG CAPSULE 90S, with a potential value of $23,537.16 and a completion date of February 27, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 140 MG CAPSULE 90S, a prescription medication, with a ceiling value of $24,350.61. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award date is May 5, 2025, and the ultimate completion date is May 27, 2025. This contract is not set aside for...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The order is for the supply of IMBRUVICA 140 MG CAPSULE 90S, a specialty medication, with a potential value of $7,845.72 and a completion date of March 4, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract, valued at $23,537.16, to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of IMBRUVICA 140 MG CAPSULE 90S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...